Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of three antioxidant compounds (N-acetyl cysteine, vitamin E, and vitamin C) that work synergistically to combat oxidative stress in the body. This combination has been studied for its protective effects against various conditions including migraine, chemotherapy-induced toxicity, liver damage, and mitochondrial diseases. ## Composition and Mechanism This combination consists of three distinct antioxidants: 1. **N-acetyl cysteine (NAC)** - A modified form of the amino acid cysteine that helps the body produce glutathione, a powerful antioxidant. NAC can break down mucus, protect against drug reactions, and has been used for acetaminophen poisoning[4][8]. 2. **Vitamin E** - A fat-soluble antioxidant that protects cell membranes from oxidative damage. 3. **Vitamin C** - A water-soluble antioxidant that works synergistically with other antioxidants to neutralize free radicals. Together, these compounds provide comprehensive antioxidant protection throughout the body's tissues and cellular compartments. ## Medical Applications Research has shown this combination may be beneficial for: - **Migraine Prevention**: A randomized, double-blind study found that this combination (referred to as NEC) significantly reduced headache and migraine frequency and intensity compared to placebo[2]. - **Chemotherapy Protection**: Japanese researchers found that this antioxidant combination protected against chemotherapy-induced heart damage without interfering with the effectiveness of the chemotherapy itself[3][6]. - **Liver Protection**: Studies suggest these antioxidants may reduce hepatotoxicity from medications like amiodarone by increasing glutathione levels and reducing oxidative stress[1]. - **Mitochondrial Disease**: NAC and vitamin E showed promising results in mitochondrial disease models, prolonging lifespan in affected worms and protecting zebrafish from brain damage. These compounds are considered lead candidates for clinical trials in mitochondrial disease patients[7]. - **Cyclophosphamide-Induced Ovarian Toxicity**: Co-administration of NAC and vitamin E significantly decreased side effects of cyclophosphamide, particularly in ovarian tissue[5]. The combination appears to work by reducing oxidative stress throughout the entire cell, not just within mitochondria, and by decreasing inflammatory markers like IL-8 and TNF[5][7]. While each component has individual benefits, research suggests their combined use may provide enhanced protective effects against various forms of oxidative damage and inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on n-acetyl cysteine + vitamin e + vitamin c.